Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Englberger
Jonas Marschall

Showing results (11-20 of 269) with videos related to

Pageof 27
Sort By:
The Journal of Thoracic and Cardiovascular Surgery|November 28, 2013
Mechanical versus bioprosthetic mitral valve replacement in patients younger than 65 yearsThierry-Pierre Carrel, Lars Englberger
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|June 17, 2016
Another report on unfavourable long-term outcome following implantation of the Shelhigh No-React™ valved tube graftThierry Carrel, David Reineke, Lars Englberger
General Thoracic and Cardiovascular Surgery|September 27, 2017
How to treat aortic graft infection? With a special emphasis on xeno-pericardial aortic tube graftsThierry Carrel, Lars Englberger, Jürg Schmidli
Intensive Care Medicine|September 25, 2016
What's new in surgical treatment of infective endocarditis?Thierry Carrel, Lars Englberger, Jukka Takala
Infection Control and Hospital Epidemiology|November 3, 2006
Duration of methicillin-resistant Staphylococcus aureus carriage, according to risk factors for acquisitionJonas Marschall, Kathrin Mühlemann
Antimicrobial Resistance and Infection Control|August 12, 2024
Infection prevention and control in 2030: a first qualitative survey by the Crystal Ball InitiativeHugo Sax, Jonas Marschall,
Recent Patents on Cardiovascular Drug Discovery|October 6, 2012
Review of the fibrinolytic system: comparison of different antifibrinolytics used during cardiopulmonary bypassCaroline Van Aelbrouck, Lars Englberger, David Faraoni
Annals of Emergency Medicine|October 25, 2011
Update on emerging infections: news from the Centers for Disease Control and Prevention. Vital signs: central line-associated blood stream infections--United States, 2001, 2008, and 2009Stephen Y Liang, Jonas Marschall
Critical Care (London, England)|January 14, 2010
RIFLE is not RIFLE: on the comparability of resultsLars Englberger, Rakesh M Suri, Hartzell V Schaff
European Heart Journal|May 22, 2015
Cardiac perforation as a rare complication of acupunctureOlivier Wigger, Stefan Stortecky, Henriette Most, et al.
Pageof 27

Showing results (11-20 of 269) with videos related to

Sort By:
Pageof 27
The Journal of Thoracic and Cardiovascular Surgery|November 28, 2013
Mechanical versus bioprosthetic mitral valve replacement in patients younger than 65 yearsThierry-Pierre Carrel, Lars Englberger
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|June 17, 2016
Another report on unfavourable long-term outcome following implantation of the Shelhigh No-React™ valved tube graftThierry Carrel, David Reineke, Lars Englberger
General Thoracic and Cardiovascular Surgery|September 27, 2017
How to treat aortic graft infection? With a special emphasis on xeno-pericardial aortic tube graftsThierry Carrel, Lars Englberger, Jürg Schmidli
Intensive Care Medicine|September 25, 2016
What's new in surgical treatment of infective endocarditis?Thierry Carrel, Lars Englberger, Jukka Takala
Infection Control and Hospital Epidemiology|November 3, 2006
Duration of methicillin-resistant Staphylococcus aureus carriage, according to risk factors for acquisitionJonas Marschall, Kathrin Mühlemann
Antimicrobial Resistance and Infection Control|August 12, 2024
Infection prevention and control in 2030: a first qualitative survey by the Crystal Ball InitiativeHugo Sax, Jonas Marschall,
Recent Patents on Cardiovascular Drug Discovery|October 6, 2012
Review of the fibrinolytic system: comparison of different antifibrinolytics used during cardiopulmonary bypassCaroline Van Aelbrouck, Lars Englberger, David Faraoni
Annals of Emergency Medicine|October 25, 2011
Update on emerging infections: news from the Centers for Disease Control and Prevention. Vital signs: central line-associated blood stream infections--United States, 2001, 2008, and 2009Stephen Y Liang, Jonas Marschall
Critical Care (London, England)|January 14, 2010
RIFLE is not RIFLE: on the comparability of resultsLars Englberger, Rakesh M Suri, Hartzell V Schaff
European Heart Journal|May 22, 2015
Cardiac perforation as a rare complication of acupunctureOlivier Wigger, Stefan Stortecky, Henriette Most, et al.
Pageof 27